Clinical Trials Browser

Phase 2 × Neoplasms × Tetrahydrouridine × Clear all

NCT02664181 2024-09-03

PRECISE

Phase 2 Completed

13 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms